Company Overview - Supernus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases [3][4] - The company's diverse neuroscience portfolio includes approved treatments for ADHD, dyskinesia in Parkinson's disease, hypomobility in Parkinson's disease, epilepsy, migraine, cervical dystonia, and chronic sialorrhea [4] Upcoming Events - Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in the Barclays Global Healthcare Conference on March 11, 2025, with a fireside chat scheduled for 12:30 p.m. ET [1] - The company will also be present at the Jefferies Biotech on the Beach Summit on March 12, 2025 [1] Investor Relations - A live audio webcast of the fireside chat at the Barclays Global Healthcare Conference will be available on the company's website, with an archived replay accessible for 60 days post-conference [2]

Core Insights - Encompass Health Corp. will participate in the Barclays Global Healthcare Conference scheduled for March 11-13, 2025 [1] - A live webcast of the presentation will be available on March 11, 2025, from 8:30–8:55 a.m. ET [1] Company Overview - Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the United States, with 166 hospitals across 38 states and Puerto Rico [2] - The company provides high-quality rehabilitative care for patients recovering from major injuries or illnesses, utilizing advanced technology and innovative treatments [2] - Encompass Health has received accolades such as being ranked among Fortune's World's Most Admired Companies™, Becker's Hospital Review's 150 Top Places to Work in Healthcare, and Forbes' Most Trusted Companies in America [2]